Absorption Systems is a full service nonclinical CRO developing innovative services and solutions for the pharmaceutical, biotech, medical device and regenerative medicine industry. Our services include research and testing for small molecules, large molecules, biologics, medical device and cell and gene therapy products. Our focus is to maintain accuracy, timelines, and reliability at every stage of development. For more information on the company's comprehensive contract services and applied research programs, please visit absorption.com
Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions.
Delivering superior pharmaceutical and nutraceutical performance, Ashland provides solutions for applications in tablet binding, film coating, disintegration, controlled-release formulation and drug solubilization. Ashland creates value for customers through bioavailability enhancement solutions, applications knowledge, market insight, regulatory support and a powerful product portfolio. Discover your solution at booth 411.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
BASF creates chemistry for a sustainable future offering intelligent solutions to the pharmaceutical industry. With expertise in polymer chemistry, R&D-capabilities and commitment in developing excipients, BASF creates solutions for Instant & Modified Release, Solubilization, Softgels and Skin Delivery. BASF is the leading supplier of APIs such as ibuprofen and omega-3.
Bioinicia is an innovative CDMO that develops and manufactures delivery solutions for drugs with a focus on increasing bioavailability, controlled release and targeting. Bioinicia uses proprietary processing technology to encapsulate bioactive molecules at mild conditions into ultrathin fibres or submicronized particles. Fibre/particle matrices are selected for optimized release of bioactives in transdermal/transmucosal/oral/ophthalmic/parenteral administration.
For 80 years BUCHI is a leading solution provider in laboratory technology for R & D, quality control and production worldwide. We serve a wide range of industries such as pharmaceuticals, chemicals, food & beverage, feed, environmental analysis and academia.
Cantabria Labs is a leading brand in dermatological prescription in Europe (leader in Spain, Italy and Portugal) with the aim of improving people's health and quality of life. Its presence in over 80 countries and subsidiaries in China, Italy, Morocco, Mexico and Portugal have earned it an excellent international reputation and support.
Colorcon works together with DowDuPont through the Controlled Release Alliance to bring joint resources to accelerate pharmaceutical product development efforts for controlled release and reach markets throughout the world. Colorcon has global sales and distribution rights for DowDuPont products used in controlled release and solubility enhancement pharmaceutical applications.
Corbion Biomaterials develops, manufactures and markets resorbable polymers for use in medical and pharmaceutical applications worldwide under the PURASORB® brand name. We support your developments with our products from early stage R&D to commercial manufacturing. Find out how our 40+ years of experience can be of value to your business.
CureVac is a leading mRNA-technology company with more than 19 years’ expertise in handling and optimizing this versatile molecule for medical purposes. Our proprietary technology is using mRNA as data carrier to instruct the human body to produce its own medicine. We develop cancer therapies, antibody therapies, rare diseases treatment, and prophylactic vaccines.
Dolomite Microfluidics offers a range of microfluidic systems, modules and components , and software for analysis or automation. Modularity, ease of use, innovation and scalability are common to all Dolomite products, which are used across a broad range of applications in biology, drug discovery, chemistry, food, cosmetics and academia.
Dr. August Wolff is a German, family-owned pharmaceutical manufacturer with a 113-year history and a focus on dermatology, gynecology and R&D. The major brands are Linola (dry skin) and Vagisan (women’s health). Based in Bielefeld/ Germany, Dr. Wolff employs 670 and generates a turnover of 300+ million Euro in 60 markets.
Biodegradable polymers optimized for use in sustained release delivery systems, including targeted delivery, nucleic acid administration, and more. We offer an extensive inventory, and substantial expertise in custom synthesis. LACTEL polymers are in numerous marketed pharmaceuticals approved by the FDA and others.
Evonik, a global leader in specialty chemicals, provides drug delivery technologies, API manufacturing, intermediates & amino acids. Delivery technologies include development services, solubility enhancement, functional excipients, lipid nanoparticles, and GMP manufacturing for oral and parenteral formulations. Advanced delivery technologies provided for small molecules, peptides, proteins, antibodies, and nucleic acids used in parenteral drugs.
Foster Delivery Science is a contract research and manufacturing firm specializing in hot melt extrusion of active pharmaceutical ingredients and polymers for highly regulated applications. Foster offers a wide variety of services including formulation development, feasibility, process development, scale up, validation and GMP manufacturing for clinical & commercial supplies. Foster’s inventory of downstream processing equipment is specifically designed for the manufacturing of customized drug delivery forms including: pellets, tablets, transdermal & transmucosal films, monofilaments, bioresorbable & biordurable implants as well as combination & drug eluting devices.
FUJIFILM Corporation has been focusing on health care business including pharmaceuticals. We are especially developing DDS technologies by using own nanotechnologies. Our core activities are liposome and microneedle developments. We would like to provide our DDS technologies to pharmaceutical and startup companies, and support manufacturing of commercial products in future.
Gattefossé is a leading supplier of functional excipients for improved drug delivery with expertise in solubility and oral bioavailability enhancement, sustained release, taste-masking and lubrication. Our topical excipients improve skin delivery, texture and sensoriality. We provide bespoke technical and regulatory support to accelerate our customers drug development programs.
Halozyme's proprietary ENHANZE® drug-delivery technology is based on its patented recombinant human hyaluronidase enzyme (rHuPH20). By using rHuPH20, some biologics and compounds that are administered intravenously may instead be delivered subcutaneously. This may result in improved efficiencies to the healthcare system, reduced overall administration time and reduced treatment burden for patients and their caregivers.
Inqualab is a company dedicated to the distribution of material and specialised equipment, bioreagents and consumables for laboratories. Inqualab is formed by a multidisciplinary team with extensive experience and in-depth knowledge of the sector, that make us the ideal supplier in the Spanish market.
Izon Science is the world leading manufacturer of nano-biological separation and characterisation tools. Its qEV SEC columns have rapidly become the EV separation method favored by experts. Izon’s TRPS measurement system is the only accurate, standardisable and practical method of measuring complex nano-bio particles, particularly EVs and nanomedicine products.
Janssen is the Pharmaceutical Companies of Johnson & Johnson and is working tirelessly to create a future where disease is a thing of the past by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. Janssen focuses on areas of medicine where it can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
LEO Pharma helps people achieve healthy skin. The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit. Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions. LEO Pharma is headquartered in Denmark with a global team of 5,500 people, serving 76 million patients in 130 countries. In 2018, the company generated net sales of DKK 10,410 million. For more information, go to: www.linkedin.com/company/leo-pharma or www.leo-pharma.com
LTS is a leading technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (“TTS”) and Oral Thin Films (“OTF”) for the pharmaceutical industry. Additional to its core technologies, LTS invests into emerging drug delivery platforms such as Micro Array Patches enabling transdermal delivery of large molecule, vaccines and biological actives.
Lubrizol LifeSciences is a total solutions partner for pharmaceutical manufacturers. LifeSciences specializes in helping customers from concept to commercialization and is a preferred Contract Development and Manufacturing Organization (CDMO) for complex pharmaceuticals providing differentiated polymers and excipients, state-of-the-art design, development and contract manufacturing services including drug-eluting device solutions.
Luye’s research and development (“R&D”) activities are located in China, US (Boston and Princeton) and Europe and organized around four platforms — long-acting and extended release technology, liposome and targeted drug delivery, transdermal drug delivery systems and new compounds. The Group has a pipeline of 27 product candidates in the PRC including 9 oncology products, 4 cardiovascular and metabolism products, and 14 CNS products, as well as 6 in the U.S. or Europe in various stages of development.
Malvern Panalytical is a world leader in analytical characterization, creating expert solutions for the challenges associated with maximizing productivity, developing better quality products and getting them to market faster. We provide superior, customer-focused technologies, solutions and services which deliver tangible economic impact through chemical, biophysical and structural analysis. www.malvernpanalytical.com
Pharmaceutics is an academic open access journal published by MDPI. It provides an interdisciplinary forum for publications which advance the fields of (i) pharmaceutical engineering, (ii) formulation and dosage form design, (iii) drug delivery and related biotechnology, and (iv) biopharmaceutics. The journal aims to serve the community and to provide cutting-edge content for their research. Pharmaceutics is indexed by SCIE (IF 3.746, ranks 52/261 (Q1) in the category of Pharmacology & Pharmacy), PubMed and Scopus; it also is a member of DOAJ. http://www.mdpi.com/journal/pharmaceutics
Microfluidics International Corp., a unit of IDEX MPT, Inc. manufactures fluid material processors for unparalleled cell disruption, microencapsulation, nanoemulsions, dispersions and deagglomeration. Microfluidizer™ technology converts fluid pressure more efficiently into shear forces, leading industry performance standards in high pressure homogenization. Microfluidics sets the standard for nanoemulsion and nanoparticle applications.
Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases.
Sponsoring Journals from the American Chemical Society
· Molecular Pharmaceutics: The preeminent journal at the interface of drug discovery & development
· Bioconjugate Chemistry: Cutting-edge forum in conjugation chemistry & biochemistry
Read the Latest Issues & Submit Your Research: pubs.acs.org
Nisso Chemical provides NISSO HPC, a high quality excipient for the pharmaceutical industry, offering hydroxypropyl cellulose in a wide range of viscosities and particle size formats for diverse applications, providing solutions for direct compression, roller compaction, wet granulation, extrusion, drug solubility enhancement, orodispersible tablets, controlled release matrices, and film coating.
NOF Corporation is the leading manufacturer of GMP grade activated PEGs, phospholipids, ultra-pure polysorbates 20 and 80, and excipients for drug delivery products through R&D to commercial scale. We continue to provide cutting-edge products for oligonucleotide delivery, antibody-drug conjugate, hydrogel medical devices, vaccine formulation and targeted delivery of oncology drugs.
Oakwood Labs specializes in the development and aseptic manufacturing of sustained-release microsphere products, ranging in duration from weeks to one year, through the use of our patented Chroniject™ technology. Oakwood’s FDA approved cGMP aseptic facility enables partners the ability to bring products from feasibility concepts to successful commercialization.
Orbis Biosciences’ Precision Particle Fabrication® technology provides customized solutions for taste masking, extended release, enteric coatings, and pulsatile release. This proprietary, single step manufacturing process creates uniform microparticles that optimize oral and injectable pharmaceuticals. Orbis offers robust intellectual property, formulation development, cGMP Phase 1 manufacturing, and scaled technology.
At Pfizer, we strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people. Every day Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time.
Pfanstiehl Inc. is a cGMP Manufacturer of High Purity Low Endotoxin components such as Trehalose, Sucrose, Mannitol, Maltose, Galactose (non-animal), Mannose and Ribose for Biologics, Biosimilars, Vaccines, Cell Culture Media and Injectables (liquid & lyo) located in Waukegan Illinois USA. Pfanstiehl has been in operation since 1919, focusing on both Biopharmaceutical excipients / critical components & Pharmaceutical HPAPIs / APIs (generic and on contract manufacturing base). Pfanstiehl specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin Injectable Formulation Ingredients, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients, in gram to multi-ton commercial quantities.
PharmaCircle publishes the Drug Delivery & Formulation Newsletter and in-depth reports on all areas of drug delivery, including new and novel technologies and devices. PharmaCircle’s premier database delivers a comprehensive view into drug, biologics and combination product development and innovation worldwide, providing pipeline, product, technology and business intelligence on 15,000+ companies.
PHI BIOMED is an emerging biopharmaceutical company founded by Professor Sei Kwang Hahn at POSTECH and Dr. Wonjin Park at Wonjin BioMedical Group in 2014. PHI BIOMED has developed hyaluronate based drug delivery systems, cosmetic surgery products, and tissue engineering products, and wearable healthcare devices such as smart contact lens.
The independent Phospholipid Research Center connects scientists from academia and industry all over the world with the aim to discover and utilize the full potential of phospholipids. Phospholipids are already widely used in registered pharmaceutical formulations. However, their use could still be further extended, as they might be able to replace almost all other emulsifiers, solubilizers and surfactants. To build up the knowledge on phospholipids we foster the dialog and exchange between various areas of research by - Organising and sponsoring symposia, meetings and workshops - Sponsoring PhD theses and Postdoc research projects at universities and (non-profit) research institutes - Providing information and literature. Please find more information on our homepage www.phospholipid-institute.com
Polymun is a privately held CMO near Vienna, Austria. Core activities are contract development and manufacturing of biopharmaceuticals as well as liposomal formulations. Polymun operates in accordance with GMP guidelines and holds an Austrian production license thus meeting all EU requirements for drug manufacturing, and is also inspected by FDA
PTS and PMC ISOCHEM will be presenting the global solutions in polypeptide-based materials for drug delivery. PTS offers the entire development of the product, from R&D through scale up to GMP manufacturing and full analytical support. Preclinical, clinical and commercial batches of starting materials, key intermediates, excipients or APIs.
Precision NanoSystems Inc (PNI) creates innovative solutions for the discovery, development and manufacture of medicines and medical research. PNI’s proprietary NanoAssemblr Platform enables the rapid, reproducible, and scalable manufacture of next generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body.
ProMed specializes in the molding of silicones and thermoplastics and leverages this expertise to manufacture drug releasing implants and combination devices. From clinical trial materials to commercial products, ProMed supports pharmaceutical and medical device groups for controlled release formulations including subcutaneous, orthopedic, cardiovacular, and ophthalmic implants, intravaginal rings, and steroid eluting components.
Recipharm is a leading contract development and manufacturing organisation (CDMO) headquartered in Stockholm, Sweden. We operate 20+ development and manufacturing facilities in Europe, the US and India. For over 20 years we have been there for our clients providing pharmaceutical expertise and a full service offering. For more information, please visit www.recipharm.com
Recro is the solid oral dose expert specializing in controlled substance and extended release formulations to your exact standards. No matter the scope of your project, we deliver — streamlining product formulation and manufacturing from concept to clinic to commercial scale.
Seqens is a world leader in pharmaceutical synthesis, providing development and manufacturing services at all stages of active ingredient’s life cycle (clinical to generic stage including functional excipients) in total compliance with the strictest quality, safety and environmental standards.
Drug Delivery & Medical Materials Portfolio : Expansorb® (biodegradable PLA/PLGA polymers), Vit-E TPGS (solubilizer excipient) & PEKK (durable polymer)
Simulations Plus is the premier developer of modeling & simulation solutions supporting drug discovery and development. With subsidiary companies Cognigen & DILIsym, we provide easy-to-use software (including GastroPlus™, ADMET Predictor™, KIWI™, and DILIsym®) and PBPK modeling, pharmacometrics, and systems toxicology/pharmacology consulting to assist with safety risk assessment and preclinical/clinical development.
SOTAX is a global leader in providing innovative solutions for pharmaceutical testing. The company offers high-quality dissolution testing systems, physical tablet testing instruments, automated sample preparation workstations for composite assay and content uniformity testing, as well as associated technical and application services. In 2013, the products of the Dr. Schleuniger® Pharmatron brand have been integrated into the SOTAX product portfolio and strengthen the company’s expertise in the physical testing segment.
SwRI® provides extensive contract R&D capabilities, including the development of custom encapsulation and controlled release formulations for applications ranging from pharmaceuticals to consumer and diversified products. Capsules and particles can be prepared in sizes from nanometers to several millimeters. Biomaterials, materials development, synthesis, and modeling capabilities are also available.
Springer Nature is one of the world’s leading global research, educational and professional publishers, home to an array of respected and trusted brands providing quality content through a range of innovative products and services. Springer Nature is the world’s largest academic book publisher and numbers almost 13,000 staff in over 50 countries. www.springernature.com
Stable Micro Systems texture analysers have the ability to measure the hardness of granules or micro spheres, tablet disintegration and swelling and will perform mucoadhesion and bioadhesion measurements. Visit our booth to have a full demonstration of the instruments and discuss your application in more detail with our product specialists.
Teledyne Hanson Research specializes in dissolution, diffusion, and disintegration testing instruments for the pharmaceutical industry. Founded by the innovator of the modern six-vessel dissolution tester, Hanson’s instruments set the standard for quality, innovation, automation, and long-term value, helping scientists work smarter, faster, and more accurately.
BY YOUR SIDE - FROM IDEA TO MARKET
We are your full service CDMO for transdermal patches and oral films. As our customer, you may expect premium quality and full regulatory compliance. We handle all steps of drug development and manufacturing. Our technologies are made in Germany, safeguarded by our quality systems under full cGMP.
Wyatt Technology® is the recognized leader in instrumentation for determining the absolute molar mass, size, charge and interactions of macromolecules and nanoparticles in solution. These tools include: in-line multi-angle static light scattering, high-throughput dynamic light scattering, differential refractometry, electrophoretic mobility, differential viscosity, field flow fractionation and automated composition gradient.